210 related articles for article (PubMed ID: 38401917)
21. Evolving paradigms for new agent development in pediatric oncology.
Flynn A; Fox E
Curr Opin Pediatr; 2018 Feb; 30(1):10-16. PubMed ID: 29176356
[TBL] [Abstract][Full Text] [Related]
22. The Promise and the Reality of Genomics to Guide Precision Medicine in Pediatric Oncology: The Decade Ahead.
Evans WE; Pui CH; Yang JJ
Clin Pharmacol Ther; 2020 Jan; 107(1):176-180. PubMed ID: 31563145
[TBL] [Abstract][Full Text] [Related]
23. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
24. Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'.
Langenberg KPS; Meister MT; Bakhuizen JJ; Boer JM; van Eijkelenburg NKA; Hulleman E; Ilan U; Looze EJ; Dierselhuis MP; van der Lugt J; Breunis W; Schild LG; Ober K; van Hooff SR; Scheijde-Vermeulen MA; Hiemcke-Jiwa LS; Flucke UE; Kranendonk MEG; Wesseling P; Sonneveld E; Punt S; Boltjes A; van Dijk F; Verwiel ETP; Volckmann R; Hehir-Kwa JY; Kester LA; Koudijs MMJ; Waanders E; Holstege FCP; Vormoor HJ; Hoving EW; van Noesel MM; Pieters R; Kool M; Stumpf M; Blattner-Johnson M; Balasubramanian GP; Van Tilburg CM; Jones BC; Jones DTW; Witt O; Pfister SM; Jongmans MCJ; Kuiper RP; de Krijger RR; Wijnen MHW; den Boer ML; Zwaan CM; Kemmeren P; Koster J; Tops BBJ; Goemans BF; Molenaar JJ
Eur J Cancer; 2022 Nov; 175():311-325. PubMed ID: 36182817
[TBL] [Abstract][Full Text] [Related]
25. Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
Zolotovskaia MA; Sorokin MI; Petrov IV; Poddubskaya EV; Moiseev AA; Sekacheva MI; Borisov NM; Tkachev VS; Garazha AV; Kaprin AD; Shegay PV; Giese A; Kim E; Roumiantsev SA; Buzdin AA
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111026
[TBL] [Abstract][Full Text] [Related]
26. Molecular Tumor Boards in Clinical Practice.
Luchini C; Lawlor RT; Milella M; Scarpa A
Trends Cancer; 2020 Sep; 6(9):738-744. PubMed ID: 32517959
[TBL] [Abstract][Full Text] [Related]
27. Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors.
Ramkissoon SH; Bandopadhayay P; Hwang J; Ramkissoon LA; Greenwald NF; Schumacher SE; O'Rourke R; Pinches N; Ho P; Malkin H; Sinai C; Filbin M; Plant A; Bi WL; Chang MS; Yang E; Wright KD; Manley PE; Ducar M; Alexandrescu S; Lidov H; Delalle I; Goumnerova LC; Church AJ; Janeway KA; Harris MH; MacConaill LE; Folkerth RD; Lindeman NI; Stiles CD; Kieran MW; Ligon AH; Santagata S; Dubuc AM; Chi SN; Beroukhim R; Ligon KL
Neuro Oncol; 2017 Jul; 19(7):986-996. PubMed ID: 28104717
[TBL] [Abstract][Full Text] [Related]
28. Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies.
Bruinooge SS; Sherwood S; Grubbs S; Schilsky RL
J Oncol Pract; 2019 Nov; 15(11):575-583. PubMed ID: 31386607
[TBL] [Abstract][Full Text] [Related]
29. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
[TBL] [Abstract][Full Text] [Related]
30. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology.
Tao JJ; Schram AM; Hyman DM
Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700
[TBL] [Abstract][Full Text] [Related]
31. A decision support framework for genomically informed investigational cancer therapy.
Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
[TBL] [Abstract][Full Text] [Related]
32. A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Mateo J; Chakravarty D; Dienstmann R; Jezdic S; Gonzalez-Perez A; Lopez-Bigas N; Ng CKY; Bedard PL; Tortora G; Douillard JY; Van Allen EM; Schultz N; Swanton C; André F; Pusztai L
Ann Oncol; 2018 Sep; 29(9):1895-1902. PubMed ID: 30137196
[TBL] [Abstract][Full Text] [Related]
33. Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.
Chae YK; Pan AP; Davis AA; Patel SP; Carneiro BA; Kurzrock R; Giles FJ
Mol Cancer Ther; 2017 Dec; 16(12):2645-2655. PubMed ID: 29203694
[TBL] [Abstract][Full Text] [Related]
34. Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries.
Cardona AF; Arrieta O; Ruiz-Patiño A; Sotelo C; Zamudio-Molano N; Zatarain-Barrón ZL; Ricaurte L; Raez L; Álvarez MPP; Barrón F; Rojas L; Rolfo C; Karachaliou N; Molina-Vila MA; Rosell R
Ther Adv Respir Dis; 2020; 14():1753466620938553. PubMed ID: 32643553
[TBL] [Abstract][Full Text] [Related]
35. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Coyne GO; Takebe N; Chen AP
Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
[TBL] [Abstract][Full Text] [Related]
36. Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.
Schmidt KT; Chau CH; Price DK; Figg WD
J Clin Pharmacol; 2016 Dec; 56(12):1484-1499. PubMed ID: 27197880
[TBL] [Abstract][Full Text] [Related]
37. Role of Precision Medicine in Pediatric Oncology.
Cahaney C; Dhir A; Ghosh T
Pediatr Ann; 2022 Jan; 51(1):e8-e14. PubMed ID: 35020508
[TBL] [Abstract][Full Text] [Related]
38. Genomics and the History of Precision Oncology.
Doroshow DB; Doroshow JH
Surg Oncol Clin N Am; 2020 Jan; 29(1):35-49. PubMed ID: 31757312
[TBL] [Abstract][Full Text] [Related]
39. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
[TBL] [Abstract][Full Text] [Related]
40. Delivering on the promise of precision cancer medicine.
Berger MF; Van Allen EM
Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
